Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$397.50 USD

397.50
1,388,392

-5.93 (-1.47%)

Updated Sep 17, 2024 04:00 PM ET

After-Market: $397.50 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (3 out of 251)

Industry: Medical - Hospital

Better trading starts here.

Zacks News

David Borun headshot

Stocks Mixed as Tech Rises but Banks Stumble

The SCOTUS vacancy, the upcoming election and continued efforts at new fiscal stimulus make things interesting in the equity markets.

The Zacks Analyst Blog Highlights: UNH, CNC, HUM, ANTM and HCA

The Zacks Analyst Blog Highlights: UNH, CNC, HUM, ANTM and HCA

Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC

Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC

Zacks.com featured highlights include: SFM, ORLY, RUSHA, DPZ and HCA

Zacks.com featured highlights include: SFM, ORLY, RUSHA, DPZ and HCA

UHS or THC: Which is a Better-Positioned Stock Right Now?

Universal Health (UHS) and Tenet Healthcare (THC) are poised to grow. On comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.

Uncertainty Over Supreme Court Ruling Weighs on Healthcare

Health insurers and hospital stocks depreciate after Justice Ruth Bader Ginsburg who defended the Obamacare breathes her last.

Sumit Singh headshot

Tap These 5 Stocks With Amazing Interest Coverage Ratio

The company's creditworthiness depends on how effectively it meets its interest obligations.

Are Investors Undervaluing HCA Holdings (HCA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Why Should You Retain MEDNAX (MD) in Your Portfolio Now?

Riding on restructuring as well as cost-cutting initiatives, MEDNAX (MD) holds potential to reap benefits for investors.

Why Should You Add Universal Health (UHS) to Your Portfolio?

Riding high on segmental contributions and a solid balance sheet, Universal Health (UHS) has potential to reap benefits for investors.

What Makes Select Medical (SEM) an Attractive Investment Pick

Solid operating fundamentals and rising earnings estimate make Select Medical (SEM) a lucrative stock.

MEDNAX Divests Radiology Business to Focus on Core Operations

MEDNAX (MD) reaches an agreement with Radiology Partners to sell its MEDNAX Radiology Solutions, which will lower its debt load and restructure its business.

Why Should You Hold on to Tenet Healthcare (THC) Stock?

Riding high on divestitures and cost-reduction, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.

Acadia Healthcare, Covenant Health to Offer Mental Healthcare

Acadia Healthcare (ACHC) and Covenant Health to unveil East Tennessee Behavioral Health to cater to the mental care services of communities in and around Knoxville.

Why Should You Retain HCA Healthcare in Your Portfolio?

Gaining traction from strategic moves and a solid uptake of telehealth medicines, HCA Healthcare (HCA) holds prospects of reaping benefits for investors.

HCA (HCA) Up 3.3% Since Last Earnings Report: Can It Continue?

HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Tenet Healthcare Up 39% in a Year: Further Upside Left?

Tenet Healthcare's (THC) strategic measures and cost-controlling efforts are expected to support its margins, which in turn, might perk up its share price.

David Borun headshot

Stocks Continue to Climb, Even Without a New Stimulus Deal

Both the House and Senate leave Washington without settling on new Covid-19 aid package, but US equities grind higher anyway.

Community Health Up 118.9% in a Year: Further Upside Left?

Community Health's (CYH) strategic measures are likely to fetch revenues, which in turn, may bump up its share price.

Ensign Group's (ENSG) Q2 Earnings Beat Estimates, Rise Y/Y

Ensign Group's (ENSG) Q2 earnings results reflect better revenues from its Transitional and Skilled Services segment.

Humana's (HUM) Q2 Earnings Surpass Estimates, Improve Y/Y

Humana's (HUM) Q2 earnings reflect better revenues and solid contributions from its Retail and Healthcare Services segments.

Tenet Healthcare (THC) Q2 Earnings Beat Estimates, Rise Y/Y

Tenet Healthcare's (THC) Q2 earnings gain from operational performance, partly offset by lower revenues.

Select Medical's (SEM) Q2 Earnings Beat Estimates, Rise Y/Y

Select Medical's (SEM) second-quarter earnings performance benefits from lower expenses.

MEDNAX's (MD) Q2 Earnings Surpass Estimates, Decline Y/Y

MEDNAX's (MD) Q2 results reflect lower expenses, offset by soft revenues.

Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y

Molina Healthcare's (MOH) Q2 results reflect higher revenues and membership growth.